Form D Explorer

Form C — Neuritek Therapeutics Inc

0001665160-24-001263 · filed 2024-09-04 · via StartEngine Capital, LLC

Offering

Target: $15,000
Maximum: $1,234,999
Security type: Common Stock
Price per security: $1.5000
Deadline: —
Oversubscription: Accepted

Issuer

Name: Neuritek Therapeutics Inc
CIK: 2036176
Entity: Corporation
Jurisdiction: NY
Address: 5 EAST 57TH STREET, 18TH FL
NEW YORK, NY 10022
Phone: —

Most recent fiscal year financials

Total assets

—

Cash

—

Short-term debt

$1,500

Long-term debt

—

Revenues

—

COGS

—

Taxes paid

—

Net income

$100,981

View original on SEC EDGAR.